Seto S K, Chandler J W
Department of Ophthalmology, University of Wisconsin-Madison 53792.
Invest Ophthalmol Vis Sci. 1990 Jan;31(1):102-6.
Previous studies have shown that Langerhans cells (LC) in normal human corneas differ from their counterparts in other epithelia (eg, skin, gingival, cervical) by their lack of the thymocyte antigen T6 on their membranes. In those studies only three out of four very young infant corneas (newborn, 3-day-, 8-day-old) have displayed positive T6 staining to date. Corneas from older infants and adults have demonstrated no such staining. This study tested the capacity of corneal LC to express T6 by in vitro induction with several immunomodulating agents. Human gamma interferon (IFN gamma was tested at 1000 U/ml, 500 U/ml and 100 U/ml. Interleukin-1 (IL-1) was tested at 100 U/ml, 50 U/ml and 20 U/ml. Thymopoietin pentapeptide (TP-5) was tested at 10 micrograms/ml, 1 micrograms/ml and 0.1 microgram/ml. Combinations of these agents were also tested in a similar fashion. None of these immunomodulating agents or combinations of them were able to induce T6 expression on normal corneal LC. This may reflect an innate incapacity of these cells to express this antigen or dosage requirements in excess of those tested.
以往的研究表明,正常人类角膜中的朗格汉斯细胞(LC)与其他上皮组织(如皮肤、牙龈、宫颈)中的同类细胞不同,其细胞膜上缺乏胸腺细胞抗原T6。在那些研究中,迄今为止,四个非常年幼的婴儿角膜(新生儿、3日龄、8日龄)中只有三个显示出T6染色阳性。年龄较大的婴儿和成人的角膜没有显示出这种染色。本研究通过用几种免疫调节剂进行体外诱导,测试了角膜LC表达T6的能力。人γ干扰素(IFNγ)分别以1000 U/ml、500 U/ml和100 U/ml进行测试。白细胞介素-1(IL-1)分别以100 U/ml、50 U/ml和20 U/ml进行测试。胸腺生成素五肽(TP-5)分别以10微克/毫升、1微克/毫升和0.1微克/毫升进行测试。这些试剂的组合也以类似方式进行了测试。这些免疫调节剂或它们的组合均不能诱导正常角膜LC表达T6。这可能反映出这些细胞天生就无法表达这种抗原,或者剂量要求超过了所测试的范围。